About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 60 adults, photoaged skin
- Sample size
- 60 (30/30)
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 August 2026
Limitations
Primary clinical endpoint not significant at 6 months; full product formulation beyond GHK-Cu not confirmed.
Cited in
Fibrillin-1 deposition over six months
GHK-Cu · Research finding
LimitedTopical product, one trial, adverse events not reported in the abstract
GHK-Cu · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.